Posted on 25 October 2017
The ISPOR Annual European Congress opens next weekend, exploring the 'Evolution of Value in Healthcare'.
It's a great chance to learn more about our work, and to meet researchers working in key areas of health economics policy and methods development.
Short courses
- Development of Conceptual Models
Saturday 4 November
8.00am - 12 noon
with Beth Woods- Mapping to Estimate Utility Values from Non-Preference Based Outcome Measures
Sunday 5 November
8.00am - 12 noon
with Andrea Manca
Issues panels
- IP4: Value Added Medicines: Time to Adjust the Health Technology Assessment Decision Frameworks?
Monday 6 November
2.15 - 3.15pm
with Michael Drummond
- IP10: Does Valuation of Innovation in Appraisal of New Technologies Provide Appropriate Incentives for Manufacturers and Access for Patients?
Tuesday 7 November
8.45 - 9.45am
with Mark Sculpher and Karl Claxton- IP16: Managed Entry Schemes for Medical Devices: Great Opportunity or Major Challenge?
Tuesday 7 November
4.45 - 5.45pm
with Michael Drummond
Workshops
- W5: Sustainable Funding and Fair Pricing for Orphan Drugs: What are the Solutions?
Monday 6 November
3.45 - 4.45pm
with Michael Drummond- W6: Generating Real-world Evidence for Real-world Decisions: Application of Advanced Methods
Monday 6 November
3.45 - 4.45pm
with Mark Sculpher- W7: Value of Information Analysis for Research Decisions: Emerging Good Practice Recommendations from the ISPOR VOI Task Force
Monday 6 November
5.00 - 6.00pm
with Claire Rothery- W15: Time for a Change? Alternative Approaches to Modelling in Cancer Value Assessments
Tuesday 7 November
4.45 - 5.45pm
with Beth Woods and Marta Soares- W19: Generating Evidence to Support Off-label Higher Value Cancer Treatment Regimens
Wednesday 8 November
10.00 - 11.00am
with Mark Sculpher
Educational symposia
- Universal Value: The Way Forward?
Wednesday 8 November
7.30 - 8.30am
with Michael Drummond
Podium presentations
- P4: Research on Methods
Monday 6 November
2.15 - 3.15pm
with Andrea Manca- P9: Medical Device and Diagnostics Studies MD3: Cost-effectiveness of Diagnosis: From Tests to Long-term Outcomes and Costs
Tuesday 7 November
8.45 - 9.45am
with Rita Faria
Posters
- PMD88: Cost-effectiveness of High-throughput, Non-invasive Prenatal Testing for Fetal Rhesus D Status
Tuesday 7 November
8.45am - 1.30pm (author discussion 12.30 - 1.30pm)
with Pedro Saramago Goncalves- PCV83: The Impact of Missed Treatment Opportunities in Outcomes in Hospitalised Heart Failure Patients: Modelling Analysis Based on the National Heart Failure Audit
Tuesday 7 November
8.45am - 1.30pm (author discussion 12.30 - 1.30pm)
with Simon Walker- PMD115: Public Perceptions, Attitudes and Willingness to Pay Towards a Medical Device for Detecting Foot Ulceration in People with Diabetes
Tuesday 7 November
8.45am - 1.30pm (author discussion 12.30 - 1.30pm)
with Fan Yang- PRM143: Tackling Network Meta-analysis Methodological Challenges: A case Study on Biologic Treatments for Moderate to Severe Plaque Psoriasis in Children and Young People
Wednesday 8 November
8.45am - 2.00pm (author discussion 1.00 - 2.00pm)
with Ana Duarte